Intercellular Adhesion Molecule Dynamics in Immune Response

Intercellular adhesion molecules orchestrate critical phases of immune defence by regulating the interactions between leukocytes, antigen-presenting cells and vascular endothelium. These glycoproteins, chiefly ICAM-1, ICAM-2 and ICAM-3, belong to the immunoglobulin superfamily and bind β2 integrins such as LFA-1 and Mac-1. Their dynamic modulation of expression and conformation underpins leukocyte arrest, firm adhesion, transendothelial migration and immunological synapse formation. Conformational shifts in integrins triggered by antigen receptor engagement refine adhesion strength, allowing T cells to adjust cytotoxic responses to varying antigenic stimuli. Conversely, the upregulation of ICAMs by proinflammatory cytokines establishes feedback loops that amplify recruitment and activation of immune effectors. Disruption of these finely tuned dynamics contributes to impaired host defence, chronic inflammation and tumour immune evasion. Understanding the spatial organisation and temporal regulation of adhesion molecules is thus essential for manipulating immune traffic in infection, autoimmunity and cancer.

Research from Nature Portfolio

Recent studies have revealed that LFA-1 molecules assemble into nanoclusters at the immunological synapse, providing a discrete platform that translates T-cell receptor engagement into graded adhesive interactions. This nanoscale organisation permits T cells to calibrate cytotoxic potency according to antigen stimulation strength, licence killing decisions and maintain sensitivity to low-abundance targets. In parallel, investigation of intercellular adhesion molecule expression in aggressive carcinoma subtypes has shown that proinflammatory cytokines induce ICAM-1 on tumour cells, promoting the formation of lymphoid aggregates within the tumour microenvironment. These ectopic structures support local antigen presentation and lymphocyte activation, suggesting that inducible ICAM-1 expression underlies tertiary lymphoid structure development and may represent a biomarker or therapeutic target in inflammation-associated cancers.

Research from all publishers

Work outside the Nature journal network has spotlighted a pathogenic ICAM-1–fibrinogen interaction that safeguards lung carcinoma cells from apoptosis. Ligation of ICAM-1 by the fibrinogen γ chain maintains survival signalling via SHP-2 association and Akt–ERK activation, while monoclonal antibodies that block this axis trigger tumour cell death and suppress xenograft growth. Complementary reviews have synthesised evidence that β2 integrin–ICAM adhesion pairs not only mediate leukocyte adhesion and transmigration but also propagate bidirectional signals influencing cell differentiation and cytokine release. Detailed analyses of ICAM-1 structure and gene regulation have further delineated its role in cardiovascular disease, autoimmunity and infection, and have catalogued current and prospective therapies aimed at modulating ICAM-1 in diverse pathological contexts.

Intercellular Adhesion Molecule Dynamics in Immune Response publication trend

The graph below shows the total number of articles in intercellular adhesion molecule dynamics in immune response across all publications each year (not limited to Nature Index journals).

Technical terms

Intercellular adhesion molecules (ICAMs): Cell-surface immunoglobulin-like proteins that bind leukocyte integrins to mediate adhesion and signalling.

LFA-1: A leucocyte β2 integrin composed of CD11a/CD18 that binds ICAMs to support immune cell arrest and activation.

Immunological synapse: The organised interface between a lymphocyte and an antigen-presenting cell where signalling and adhesion are coordinated.

Nanoclusters: Submicrometre assemblies of adhesion receptors that amplify and regulate cell-surface signalling events.

Tertiary lymphoid structures (TLS): Ectopic lymphoid aggregates formed in non-lymphoid tissues during sustained inflammation, facilitating local immune responses.

References

1. LFA-1 nanoclusters integrate TCR stimulation strength to tune T-cell cytotoxic activity. Nature Communications (2024).
2. Neoplastic ICAM-1 protects lung carcinoma from apoptosis through ligation of fibrinogen. Cell Death & Disease (2024).
3. ICAMs in Immunity, Intercellular Adhesion and Communication. Cells (2024).
4. ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes. Scientific Reports (2018).